Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism

ESSENTIALS: Clinical trials demonstrated the gain of extended anticoagulation among patients with VTE. In a real‐world setting, we evaluated outcomes of extended rivaroxaban use for unprovoked VTE. Extended rivaroxaban treatment lowered the risk of recurrent VTE among unprovoked VTE patients. Extend...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Jeffrey S., Seheult, Roger, Laliberté, François, Crivera, Concetta, Lejeune, Dominique, Xiao, Yongling, Schein, Jeff, Lefebvre, Patrick, Kaatz, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055557/
https://www.ncbi.nlm.nih.gov/pubmed/30046707
http://dx.doi.org/10.1002/rth2.12050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055557/
https://www.ncbi.nlm.nih.gov/pubmed/30046707
http://dx.doi.org/10.1002/rth2.12050

Ejemplares similares